Northrop Grumman Corporation

ticker: NOC step: 01 generated: 2026-05-12 source: quick-research

Northrop Grumman Corporation (NOC) — Business Overview

Business Description

Northrop Grumman is one of the top-5 US defense primes (alongside Lockheed Martin, RTX, General Dynamics, Boeing), uniquely positioned at the intersection of strategic deterrence (B-21 Raider next-gen stealth bomber + LGM-35A Sentinel ICBM), space systems (national security space, missile defense), mission systems (radar, sensors, cyber, electronic warfare), and defense systems (munitions, weapons). The company is led by CEO Kathy Warden. FY25 revenue ~$44B; record $95.7B backlog. The B-21 Raider production ramp (25% acceleration agreement) + Sentinel ICBM restructuring + CCA / autonomous systems + munitions expansion create a multi-year "Deterrence Super-Cycle" thesis with material upside in 2027-28.

Revenue Model

Four reportable segments (FY2025 revenue):

• Aeronautics Systems ($12.99B, ~29%, +8%) — B-21 Raider, B-2 Spirit, F-35 (sub-contract), Triton/Global Hawk surveillance UAS, X-47 autonomy, E-2D Hawkeye.
• Mission Systems ($12.51B, ~29%, +9.7%) — Radar (APG-83, APG-81 for F-35), electronic warfare (SEWIP), C4I, advanced computing, cyber, naval weapons.
• Space Systems ($10.77B, ~25%, -8.2%) — Sentinel ICBM (LGM-35A), national security space, NGAD space components, Cygnus cargo (ISS), missile defense (NGI Next Generation Interceptor).
• Defense Systems ($8.00B, ~18%) — Munitions, weapons, ground combat, propellants, fire-control.

Revenue is overwhelmingly long-cycle (multi-year cost-plus + fixed-price contracts) with US Government as ~80%+ customer.

Products & Services

• B-21 Raider Stealth Bomber: Successor to B-2; 25% production acceleration agreement; multi-decade program. Combat-ready 2029.
• Sentinel ICBM (LGM-35A): Replaces Minuteman III; under restructuring through late 2026; test launch 2027; operational early 2030s. $200M near-term + $2.5B multi-year capex commitment.
• Triton + Global Hawk UAS: Maritime + high-altitude surveillance.
• Cygnus: ISS cargo resupply (NASA).
• NGI (Next Generation Interceptor): Missile defense; competing with Lockheed.
• Collaborative Combat Aircraft (CCA): Autonomous wingmen for F-35/NGAD; emerging program with material 2027-28 upside.
• APG-83 + APG-81 AESA radars: F-16 + F-35 fighter radars.
• SEWIP: Surface Electronic Warfare Improvement Program (Navy).
• Munitions / Weapons: AARGM-ER, AGM-88E, Stand-In Attack Weapon (SiAW); munitions expansion driven by Ukraine + Israel + Pacific demand.

Customer Base & Go-to-Market

• US Department of Defense (~80% of revenue): All military services + DARPA + Missile Defense Agency.
• NASA (~5%): Cygnus + space science programs.
• Foreign Military Sales (~15%): Various NATO + Pacific allies (Australia, Japan, Korea).
• Commercial: Smaller; mostly Cygnus + small business spinoffs.

Distribution: Direct US government contracts; foreign military sales via Government channels; multi-year cost-plus + fixed-price agreements.

Competitive Position

Northrop occupies a unique niche in US defense — the dominant stealth bomber + ICBM + national security space prime:

1. B-21 Raider sole-source — Only fifth-generation stealth bomber in development; multi-decade $200B+ lifetime program value.
2. Sentinel ICBM sole-source — Replaces Minuteman III; multi-decade $140B+ program.
3. National security space leadership — Cygnus + classified space programs.
4. Mission Systems radar/EW depth — Sensors + electronic warfare leadership.

Competitive positioning vs. peers:

• Lockheed Martin — Larger; F-35 dominant; NGI competitor; Aegis.
• RTX (Raytheon Technologies) — Munitions + space + Pratt & Whitney engines.
• General Dynamics — IT services + munitions + naval.
• Boeing Defense — F-15EX + KC-46 + apache; recovering from execution issues.

Structural advantages:

1. Backlog at record $95.7B — Multi-year revenue visibility.
2. Defense budget tailwind — US FY2027 budget request proposes +44% increase; NATO 2% commitments + Pacific deterrence buildup.
3. B-21 + Sentinel multi-decade programs — Long-lifecycle revenue streams; high switching costs.
4. Mission Systems mix — Higher-margin technology content vs. heavy industrial.

Challenges:

• Sentinel restructuring overhang — Multi-billion overruns, Department of Defense oversight; could continue compressing margins.
• Space Systems -8.2% in FY25 — Off legacy program rolls + Sentinel restructuring.
• B-21 cost overruns — Fixed-price LRIP contract creates margin risk.
• Supply chain + workforce constraints — Critical components, skilled labor shortages.

Key Facts

• Founded: 1939 (Northrop Aircraft); 1994 merger with Grumman
• Headquarters: Falls Church, Virginia
• Employees: ~100,000+
• Exchange: NYSE
• Sector / Industry: Industrials / Aerospace & Defense
• Market Cap: ~$80B
• FY2024 Revenue: $41.0B (+4%)
• FY2025 Revenue: ~$44B
• Backlog: $95.7B record
• B-21 Production Acceleration: 25% capacity increase agreement
• Q1 2026 Revenue: $9.9B; EPS $6.14
• 2026 Revenue Guide: $43.5–44.0B
• 2026 Segment Operating Margin Guide: Low-to-mid 11% range
• FY2025 Free Cash Flow: $3.3B (+26% YoY)
• Dividend Yield: ~1.5%
• CEO: Kathy Warden (since 2019)

ticker: NOC step: 04 generated: 2026-05-12 source: quick-research

Northrop Grumman Corporation (NOC) — Financial Snapshot

Income Statement Summary

Segment Detail (FY2025 — Revenue)

Q1 2026 Results

FY2026 Guidance

Cash Flow & Capital Allocation (FY2025)

Key Ratios (approximate)

• P/E: ~21x (FY26E EPS ~$28) | EV/EBITDA: ~14x | FCF Yield: ~4%
• Revenue Growth (FY25): +7% (Backlog +6%)
• Segment Operating Margin: ~11.2%
• Dividend Yield: ~1.5%
• Book/Bill Ratio: >1.1x (multi-year revenue visibility)

Growth Profile

FY25 was a strong year operationally:

• Revenue +7% to $44B
• FCF +26% to $3.3B
• Backlog at record $95.7B
• B-21 25% production acceleration agreement signed
• Sentinel restructuring progressing toward late-2026 conclusion

Q1 2026 setup ($9.9B revenue + $6.14 EPS) confirms operational momentum continuing.

The 2026-2028 narrative:

• 2026: Production ramps + Sentinel restructuring conclusion (margin pressure subsides)
• 2027: B-21 acceleration material; CCA program ramps; Sentinel test launch
• 2028: B-21 + CCA + munitions all at higher production cadence; margins expand

CEO Warden has framed 2026 as a "balanced" year with major revenue impacts pushed to 2027–28. The 2027-28 setup includes "unpriced upside" not in current guidance from B-21 acceleration + CCA + munitions expansion.

Forward Estimates

FY2026 Guide:

• Revenue: $43.5–44.0B (flat to slightly up)
• Segment Operating Margin: 11.2–11.6%
• Adjusted EPS: ~$27.50–29.00 consensus

Bull case: B-21 acceleration starts contributing in late 2026; Sentinel restructuring concludes cleanly; CCA program awards; munitions expansion drives 2027 revenue +12-15%; multiple expands to 24x P/E; stock could reach $700+ vs. $565 currently. Bear case: B-21 cost overruns; Sentinel margin pressure extends; defense budget delays; multiple compresses to 18x P/E. Consensus targets ~$650–720 vs. trading ~$555–585 (~12–25% implied upside).